4/16
10:55 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
4/10
10:19 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
4/10
09:41 am
lbph
Rating for LBPH
Low
Report
Rating for LBPH
3/18
03:15 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $32.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $32.00 price target on the stock.
3/18
03:15 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $32.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $32.00 price target on the stock.
3/18
03:12 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
3/18
02:59 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
3/13
12:08 pm
lbph
Rating for LBPH
Medium
Report
Rating for LBPH
3/13
09:41 am
lbph
Rating for LBPH
Low
Report
Rating for LBPH
3/13
09:41 am
lbph
Rating for LBPH
Low
Report
Rating for LBPH
2/16
07:28 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $40.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $40.00 price target on the stock.
2/16
06:43 am
lbph
Rating for LBPH
Low
Report
Rating for LBPH
2/16
06:43 am
lbph
Rating for LBPH
Low
Report
Rating for LBPH
2/15
04:10 pm
lbph
Longboard Pharmaceuticals initiated with a Buy at Citi
Low
Report
Longboard Pharmaceuticals initiated with a Buy at Citi